Hong, Jung Yong

Comprehensive pharmacogenomic characterization of gastric cancer

Sa, J. K., Hong, J. Y., Lee, I.-K., Kim, J.-S., Sim, M.-H., Kim, H. J., An, J. Y., Sohn, T. S., Lee, J. H., Bae, J. M., et al. (2020) · Genome Medicine

Gastric Cancer Management and OutcomesCancer Genomics and Diagnostics

Cited by 46

Clinical practice guideline and real-life practice in hepatocellular carcinoma: A Korean perspective

Goh, M. J., Sinn, D. H., Kim, J. M., Lee, M. W., Hyun, D. H., Yu, J. I., Hong, J. Y., & Choi, M. S. (2023) · Clinical and Molecular Hepatology

Hepatocellular Carcinoma Treatment and PrognosisClinical practice guidelines implementation

Cited by 35

1660TiP First-in-human study of ABBV-969, a dual variable antibody-drug conjugate (ADC), in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC)

Berger, R., Tolcher, A. W., Dorff, T. B., Okubo, S., Abraham, L. S., Reilly, R., Stevenson, C., Wang, S., Arnold, J., Mudd, S. R., et al. (2024) · Annals of Oncology

Prostate Cancer Treatment and ResearchProtein Degradation and Inhibitors

Cited by 8